The Etiology Analysis of Myasthenia Gravis with In-Hospital Mortality in the Neurocritical Care Unit
- PMID: 40877497
- DOI: 10.1007/s12028-025-02352-8
The Etiology Analysis of Myasthenia Gravis with In-Hospital Mortality in the Neurocritical Care Unit
Abstract
Background: Our objective was to investigate the characteristics and causes of death in deceased patients with myasthenia gravis (MG).
Methods: This study conducted a retrospective analysis of data from patients with MG in the neurocritical unit at two large general hospitals in China spanning 10 years, from January 2014 to December 2023. Detailed demographic and clinical information were collected for deceased patients. Experienced physicians determined both the underlying and direct causes of death.
Results: Among 3723 patients, the overall hospitalized mortality was 79 (2.12%). Thymoma was present in 52 (65.82%) of these patients. Compared with the nonthymomatous MG (NTMG) group (n = 27), patients with thymomatous MG (TMG) (n = 52) were significantly younger at death (53.71 ± 14.01 years vs. 65.37 ± 14.61 years, p = 0.001). Septic shock was the most common underlying cause of death, affecting 32 (40.51%) patients, followed by myasthenic crisis in 18 (22.78%) patients. This trend was observed in both the TMG and NTMG groups. In the TMG group, fulminant myocarditis was the third leading underlying cause of death in 9 (17.31%) patients, whereas no cases of fulminant myocarditis were reported in the NTMG group. Among all deceased patients (n = 79), pneumonia was the most common infection, affecting 55 (69.62%) patients, followed by urinary tract infections in 14 (17.72%) patients, bloodstream infections in 13 (16.46%) patients, and intracranial infections in 7 (8.86%) patients.
Conclusions: The study suggests that thymoma may increase the risk of death, with septic shock and myasthenic crisis being the most frequent underlying causes in patients with MG.
Keywords: Mortality; Myasthenia gravis; Myasthenic crisis; Neurocritical care; Septic shock; Thymoma.
© 2025. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.
Conflict of interest statement
Declarations. Conflict of interest: No conflicts of interest are related to the research or the manuscript. The content of this article is not under consideration for publication in any other journal and has not been published in any journal. Ethical Approval/Informed Consent: This study received approval from the Medical Ethics Committee of West China Hospital, Sichuan University and Huashan Hospital, Fudan University. Because the data used did not contain any personally identifiable information, informed consent was waived.
Similar articles
-
Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.Ther Adv Neurol Disord. 2025 Jun 20;18:17562864251343573. doi: 10.1177/17562864251343573. eCollection 2025. Ther Adv Neurol Disord. 2025. PMID: 40547861 Free PMC article.
-
Weaning from mechanical ventilation in myasthenic crisis according to WEAN safe: most patients experience intermediate or prolonged weaning with no differences between early and late-onset compared to very-late onset myasthenia Gravis.Ann Intensive Care. 2025 Jul 14;15(1):95. doi: 10.1186/s13613-025-01515-2. Ann Intensive Care. 2025. PMID: 40658304 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
Cited by
-
Response to Comment on "Dynamic Impact of Leptomeningeal Collateral Status for Hemorrhagic Transformation in Patients with Acute Ischemic Stroke with Endovascular Treatment".Neurocrit Care. 2025 Sep 8. doi: 10.1007/s12028-025-02370-6. Online ahead of print. Neurocrit Care. 2025. PMID: 40921988 No abstract available.
References
-
- Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30. https://doi.org/10.1038/s41572-019-0079-y . - DOI - PubMed
-
- Habib AA, Sacks N, Cool C, et al. Hospitalizations and mortality from myasthenia gravis: trends from 2 US national datasets. Neurology. 2024;102(2):e207863. https://doi.org/10.1212/WNL.0000000000207863 . - DOI - PubMed
-
- Zhang C, Wang F, Long Z, et al. Mortality of myasthenia gravis: A national population-based study in China. Ann Clin Transl Neurol. 2023;10(7):1095–105. https://doi.org/10.1002/acn3.51792 . - DOI - PubMed - PMC
-
- Vissing J, Atula S, Savolainen M, et al. Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational study. J Neurol Neurosurg Psychiatry. 2024;95(10):919–26. https://doi.org/10.1136/jnnp-2023-333097 . - DOI - PubMed
-
- Basta I, PekmezoviC T, Peric S, et al. Survival and mortality of adult-onset myasthenia gravis in the population of Belgrade. Serbia Muscle Nerve. 2018;58(5):708–12. https://doi.org/10.1002/mus.26132 . - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources